Literature DB >> 26400642

Primary care assessment of capillaroscopy abnormalities in patients with Raynaud's phenomenon.

Rebecca Overbury1, Maureen A Murtaugh2, Aryeh Fischer3, Tracy M Frech4.   

Abstract

Raynaud's phenomenon is a clinical symptom that can commonly present to a primary care provider or generalist. Proper identification of an underlying connective tissue disease in a patient with Raynaud's could allow for the prevention of possible critical digital ischemia. Capillaroscopy is a tool which can identify abnormalities associated with connective tissue disease. Patients presenting with a complaint of Raynaud's phenomenon were assessed with capillaroscopy. In twenty consecutive Raynaud patients, 8 digits were assessed by a ×200 magnification dermatoscope and an image was obtained. Each image was assessed for the following abnormalities: drop-out (<9 capillaries in 1 mm); microhemorrhage; dilated loops; and neoangiogenesis. These 160 images were then shown to 20 primary care physicians, who assessed these same abnormalities. The interrater reliability, a measure of agreement, of individual primary care providers with the expert provider was assessed using kappa statistics. Three raters had slight agreement (in the range 0 to 0.20), one rater had fair agreement (0.21 to 0.40), 11 raters had moderate agreement (0.41 to 0.60), five raters had substantial agreement (0.61 to 0.80), and no rater had almost perfect agreement (0.81 to 1.00) (14). The total agreement from the 20 primary care providers (n = 3,156) was moderate (Κ = 0.50, 95 % CI 0.49, 0.55). For the four providers with the slight to fair interrater reliabilities, the most common disagreement was providing a positive diagnosis when the expert rater diagnosed the digit negative. Ten of the twenty primary care providers provided at least one additional diagnosis following an abnormal diagnosis (n = 35 digits or 35 % of the 1556 abnormal ratings by the primary care providers). The four providers with the poorest interrater reliabilities were not among the ten providers who participated in making these additional specific diagnoses. These providers achieved the moderate agreement with the expert provider for diagnoses of microhemorrhage (Κ = 0.64, 95 % CI 0.57, 0.70), but fair agreement with the expert provider for diagnoses of dilated (Κ = 0.27, 95 % CI 0.20, 0.34) and neoangiogenesis (Κ = 0.22, 95 %CI 0.13, 0.31). Capillaroscopy is a potentially contributive clinical exam skill that could assist primary care providers and generalists in identifying and qualifying changes associated with the common presentation of Raynaud's disease. However, formal training is needed to ensure accuracy and reproducibility. Furthermore, training and scoring systems should address time constraints of busy primary care practitioners.

Entities:  

Keywords:  Diagnostic tests; Methodology; Raynaud’s syndrome; Rheumatic diseases; Scleroderma; Systemic sclerosis

Mesh:

Year:  2015        PMID: 26400642     DOI: 10.1007/s10067-015-3062-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

Review 1.  How to perform and interpret capillaroscopy.

Authors:  Maurizio Cutolo; Alberto Sulli; Vanessa Smith
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-04       Impact factor: 4.098

2.  Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.

Authors:  Vanessa Smith; Valeria Riccieri; Carmen Pizzorni; Saskia Decuman; Ellen Deschepper; Carolien Bonroy; Alberto Sulli; Yves Piette; Filip De Keyser; Maurizio Cutolo
Journal:  J Rheumatol       Date:  2013-10-15       Impact factor: 4.666

3.  Q: When do Raynaud symptoms merit a workup for autoimmune rheumatic disease?

Authors:  Soumya Chatterjee
Journal:  Cleve Clin J Med       Date:  2013-01       Impact factor: 2.321

Review 4.  State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology?

Authors:  Maurizio Cutolo; Vanessa Smith
Journal:  Rheumatology (Oxford)       Date:  2013-04-25       Impact factor: 7.580

5.  Prevalence of scleroderma spectrum disorders in the general population of South Carolina.

Authors:  H R Maricq; M C Weinrich; J E Keil; E A Smith; F E Harper; A I Nussbaum; E C LeRoy; A R McGregor; F Diat; E J Rosal
Journal:  Arthritis Rheum       Date:  1989-08

6.  Prevalence of symptoms of Raynaud's phenomenon in general practice.

Authors:  A Silman; S Holligan; P Brennan; P Maddison
Journal:  BMJ       Date:  1990-09-22

Review 7.  Capillaroscopy.

Authors:  Maurizio Cutolo; Carmen Pizzorni; Alberto Sulli
Journal:  Best Pract Res Clin Rheumatol       Date:  2005-06       Impact factor: 4.098

8.  Assessment of nailfold capillaroscopy by x 30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon.

Authors:  E Beltrán; A Toll; A Pros; J Carbonell; R M Pujol
Journal:  Br J Dermatol       Date:  2007-03-28       Impact factor: 9.302

9.  2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Ann Rheum Dis       Date:  2013-11       Impact factor: 19.103

10.  Office capillaroscopy in systemic sclerosis.

Authors:  Murray Baron; Mary Bell; Arthur Bookman; Maura Buchignani; James Dunne; Marie Hudson; Dana Jerome; Sindhu R Johnson; Niall Jones; Elzbieta Kaminska; Terri Lupton; Jean-Pierre Mathieu; Janet Pope; Russell Steele; Suzanne Taillefer
Journal:  Clin Rheumatol       Date:  2006-12-09       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.